Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2010 Sep;120(9):3102-5. doi: 10.1172/JCI44422. Epub 2010 Aug 25.

From skin cells to hepatocytes: advances in application of iPS cell technology.

Author information

1
Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania 19107, USA. Linda.greenbaum@jefferson.edu

Abstract

The discovery several years ago that fibroblasts and other somatic cells from mice and humans can be reprogrammed to become inducible pluripotent stem (iPS) cells has created enthusiasm for their potential applications in regenerative medicine and for modeling human diseases. Two independent studies in this issue of the JCI provide evidence that iPS cells represent a promising source of hepatocytes for a wide range of applications, including cell transplantation, drug toxicity testing, patient-specific disease modeling, and even ex vivo gene therapy. But how far have we come?

PMID:
20739747
PMCID:
PMC2929747
DOI:
10.1172/JCI44422
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Society for Clinical Investigation Icon for PubMed Central
    Loading ...
    Support Center